Provides an update and defense on the stem cell initiative of the California Institute for Regenerative Medicine as of February 2006. Issues regarding the development of policies to protect the intellectual property of human stem cell researchers in California; Questions surrounding the donation of eggs for cloning; Risks of oocyte procurement for stem cell research.
